Roberto Mina
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- CAR-T cell therapy research
- COVID-19 and healthcare impacts
- Cancer Immunotherapy and Biomarkers
Papers in
- Hematology 94
- Multiple Myeloma Research and Treatments 93
- Acute Myeloid Leukemia Research 1
- Oncology 9
- CAR-T cell therapy research 6
- COVID-19 and healthcare impacts 2
- Co-authors
- Antonio Pierangelo Palumbo (15 shared papers)Francesca Gay (17 shared papers)Mario Boccadoro (16 shared papers)Sara Bringhen (14 shared papers)Sagar Lonial (5 shared papers)Alessandra Larocca (8 shared papers)Francesca Bonello (5 shared papers)Chiara Cerrato (4 shared papers)
- Journals
- Blood (13 papers)Haematologica (8 papers)The Lancet Haematology (5 papers)New England Journal of Medicine (4 papers)HemaSphere (4 papers)
- Partner nations
- ItalyUnited StatesNetherlands
In The Last Decade
Roberto Mina
94 papers receiving 2.2k citations
Roberto Mina's Hit Papers
Peers
Comparison fields: 5 of 51
- Hematology 1.9k
- Oncology 199
- Infectious Diseases 82
- Genetics 30
- Geriatrics and Gerontology 11
Countries citing papers authored by Roberto Mina
This map shows the geographic impact of Roberto Mina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Mina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Mina more than expected).
Fields of papers citing papers by Roberto Mina
This network shows the impact of papers produced by Roberto Mina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Mina. The network helps show where Roberto Mina may publish in the future.
Co-authors
The 25 scholars most cited alongside Roberto Mina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 102 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma Hit paper breakdown → | 2023 | 358 |
| 2 | 2014 | 185 | |
| 3 | 2013 | 184 | |
| 4 | Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network Hit paper breakdown → | 2023 | 143 |
| 5 | 2016 | 85 | |
| 6 | 2013 | 81 | |
| 7 | 2013 | 80 | |
| 8 | 2013 | 66 | |
| 9 | 2022 | 61 | |
| 10 | 2021 | 54 | |
| 11 | 2019 | 49 | |
| 12 | 2014 | 46 | |
| 13 | 2018 | 46 | |
| 14 | 2019 | 42 | |
| 15 | 2017 | 41 | |
| 16 | 2019 | 41 | |
| 17 | 2018 | 40 | |
| 18 | 2021 | 40 | |
| 19 | 2016 | 34 | |
| 20 | 2012 | 29 |
About Roberto Mina
Roberto Mina is a scholar working on Hematology, Oncology, Infectious Diseases, Transplantation and Genetics, having authored 102 papers that have together received 2.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (93 papers), CAR-T cell therapy research (6 papers), COVID-19 Clinical Research Studies (3 papers), COVID-19 and healthcare impacts (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Hematology (1.9k citations), Oncology (199 citations), Infectious Diseases (82 citations), Genetics (30 citations) and Geriatrics and Gerontology (11 citations). Roberto Mina has collaborated with scholars based in Italy, United States and Netherlands. Frequent co-authors include Antonio Pierangelo Palumbo, Francesca Gay, Mario Boccadoro, Sara Bringhen, Sagar Lonial, Alessandra Larocca, Francesca Bonello, Chiara Cerrato, Mattia D’Agostino and Stefania Oliva. Their work appears in journals such as Blood, Haematologica, The Lancet Haematology, New England Journal of Medicine and HemaSphere.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.